Effects of androgen ablation therapy in TRAIL death ligand and its receptors expression in advanced prostate cancer. [electronic resource]
Producer: 20100920Description: 445-51 p. digitalISSN:- 1423-0399
- Androgen Antagonists -- therapeutic use
- Antineoplastic Agents, Hormonal -- therapeutic use
- Drug Resistance, Neoplasm
- Humans
- Immunohistochemistry
- Male
- Neoplasm Staging
- Prostatic Neoplasms -- drug therapy
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- metabolism
- Receptors, Tumor Necrosis Factor -- metabolism
- TNF-Related Apoptosis-Inducing Ligand -- metabolism
- Time Factors
- Treatment Outcome
- Turkey
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.